11β-hydroxysteroid dehydrogenase type 1 activity in short small-for-ga children and in response to GH therapy

Pediatric Research

Volumn 70, Issue 2, 2011, Pages 208-212

  Zuckerman Levin, Nehama ^a   Tsivlin, Larisa ^a   Knopf, Carlos ^b   Flor, Oshrat ^a,b   Shen Orr, Zila ^b   Levin, Moshe ^a   Hochberg, Ze'ev ^a,c  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; GROWTH HORMONE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LOW BIRTH WEIGHT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SHORT SMALL FOR GESTATIONAL AGE; TREATMENT RESPONSE;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCOCORTICOIDS; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE;

EID: 79960248867     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3182226a0c     Document Type: Article

References (56)

1. Hokken-Koelega AC, De Ridder MA, Lemmen RJ, Den Hartog H, De Muinck Keizer-Schrama SM, Drop SL 1995 Children born small for gestational age: do they catch up? Pediatr Res 38:267-271
2. Karlberg J, Albertsson-Wikland K 1995 Growth in full-term small-for-gestationalage infants: from birth to final height. Pediatr Res 38:733-739
3. Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A 2007 Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab 92:804-810 (Pubitemid 46465644)
4. Dahlgren J, Wikland KA 2005 Final height in short children born small for gestational age treated with growth hormone. Pediatr Res 57:216-222 (Pubitemid 40165598)
5. Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A 2003 Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. J Clin Endocrinol Metab 88:3584-3590 (Pubitemid 37034499)
6. Barker DJ, Bull AR, Osmond C, Simmonds SJ 1990 Fetal and placental size and risk of hypertension in adult life. BMJ 301:259-262 (Pubitemid 20241224)
7. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ 1989 Weight in infancy and death from ischaemic heart disease. Lancet 2:577-580 (Pubitemid 19216205)
8. Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C, Barker DJ 1999 Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ 318:427-431 (Pubitemid 29192114)
9. Mericq V, Ong KK, Bazaes R, Pena V, Avila A, Salazar T, Soto N, Iniguez G, Dunger DB 2005 Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small-and appropriate-for-gestational-age children. Diabetologia 48:2609-2614 (Pubitemid 41738229)
10. Saenger P, Czernichow P, Hughes I, Reiter EO 2007 Small for gestational age: short stature and beyond. Endocr Rev 28:219-251 (Pubitemid 46984835)
11. Fagerberg B, Bondjers L, Nilsson P 2004 Low birth weight in combination with catch-up growth predicts the occurrence of the metabolic syndrome in men at late middle age: the Atherosclerosis and Insulin Resistance study. J Intern Med 256:254-259 (Pubitemid 39222995)
12. Jaquet D, Deghmoun S, Chevenne D, Collin D, Czernichow P, Levy-Marchal C 2005 Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth. Diabetologia 48:849-855 (Pubitemid 40767976)
13. Veening MA, Van Weissenbruch MM, Delemarre-Van De Waal HA 2002 Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab 87:4657-4661 (Pubitemid 35247057)
14. Tenhola S, Martikainen A, Rahiala E, Herrgard E, Halonen P, Voutilainen R 2000 Serum lipid concentrations and growth characteristics in 12-year-old children born small for gestational age. Pediatr Res 48:623-628
15. Hokken-Koelega AC, De Waal WJ, Sas TC, Van Pareren Y, Arends NJ 2004 Small for gestational age (SGA): endocrine and metabolic consequences and effects of growth hormone treatment. J Pediatr Endocrinol Metab 17:463-469 (Pubitemid 38931048)
16. Arends NJ, Boonstra VH, Duivenvoorden HJ, Hofman PL, Cutfield WS, Hokken-Koelega AC 2005 Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA). Clin Endocrinol (Oxf) 62:44-50 (Pubitemid 40175282)
17. Cianfarani S, Ladaki C, Geremia C 2006 Hormonal regulation of postnatal growth in children born small for gestational age. Horm Res 65:70-74 (Pubitemid 44689436)
18. Clark PM, Hindmarsh PC, Shiell AW, Law CM, Honour JW, Barker DJ 1996 Size at birth and adrenocortical function in childhood. Clin Endocrinol (Oxf) 45:721-726 (Pubitemid 27032318)
19. Murphy VE, Smith R, Giles WB, Clifton VL 2006 Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev 27:141-169
20. Tenhola S, Martikainen A, Rahiala E, Parviainen M, Halonen P, Voutilainen R 2002 Increased adrenocortical and adrenomedullary hormonal activity in 12-year-old children born small for gestational age. J Pediatr 141:477-482 (Pubitemid 35193311)
21. Phillips DI, Walker BR, Reynolds RM, Flanagan DE, Wood PJ, Osmond C, Barker DJ, Whorwood CB 2000 Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations. Hypertension 35:1301-1306 (Pubitemid 30413668)
22. Cianfarani S, Geremia C, Scott CD, Germani D 2002 Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis? Pediatr Res 51:94-99 (Pubitemid 34008216)
23. Economides DL, Nicolaides KH, Linton EA, Perry LA, Chard T 1988 Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses. Fetal Ther 3:158-164 (Pubitemid 19251193)
24. Tenhola S, Turpeinen U, Halonen P, Hamalainen E, Voutilainen R 2005 Association of serum lipid concentrations, insulin resistance index and catch-up growth with serum cortisol/cortisone ratio by liquid chromatography tandem mass spectrometry in children born small for gestational age. Pediatr Res 58:467-471 (Pubitemid 41254508)
25. Cianfarani S, Germani D, Rossi L, Argiro G, Boemi S, Lemon M, Holly JM, Branca F 1998 IGF-I and IGF-binding protein-1 are related to cortisol in human cord blood. Eur J Endocrinol 138:524-529 (Pubitemid 28238187)
26. Fruchter O, Zoumakis E, Alesci S, De Martino M, Chrousos G, Hochberg Z 2006 Intracrine modulation of gene expression by intracellular generation of active glucocorticoids. Steroids 71:1001-1006 (Pubitemid 44573302)
27. Friedberg M, Zoumakis E, Hiroi N, Bader T, Chrousos GP, Hochberg Z 2003 Modulation of 11 beta-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers. J Clin Endocrinol Metab 88:385-393 (Pubitemid 36115193)
28. Agha A, Monson JP 2007 Modulation of glucocorticoid metabolism by the growth hormone - IGF-1 axis. Clin Endocrinol (Oxf) 66:459-465 (Pubitemid 46434930)
29. Gelding SV, Taylor NF, Wood PJ, Noonan K, Weaver JU, Wood DF, Monson JP 1998 The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity. Clin Endocrinol (Oxf) 48:153-162 (Pubitemid 28091045)
30. Moore JS, Monson JP, Kaltsas G, Putignano P, Wood PJ, Sheppard MC, Besser GM, Taylor NF, Stewart PM 1999 Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. J Clin Endocrinol Metab 84:4172-4177 (Pubitemid 30644213)
31. Paulsen SK, Pedersen SB, Jorgensen JO, Fisker S, Christiansen JS, Flyvbjerg A, Richelsen B 2006 Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue. J Clin Endocrinol Metab 91:1093-1098 (Pubitemid 43357786)
32. Tiosano D, Knopf C, Koren I, Levanon N, Hartmann MF, Hochberg Z, Wudy SA 2008 Metabolic evidence for impaired 17alpha-hydroxylase activity in a kindred bearing the E305G mutation for isolate 17, 20-lyase activity. Eur J Endocrinol 158:385-392 (Pubitemid 351405004)
33. Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH 1999 Cortisol metabolism in human obesity: impaired cortisone3cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 84:1022-1027 (Pubitemid 29138237)
34. Stewart PM, Corrie JE, Shackleton CH, Edwards CR 1988 Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J Clin Invest 82:340-349 (Pubitemid 18262536)
35. Palermo M, Shackleton CH, Mantero F, Stewart PM 1996 Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf) 45:605-611 (Pubitemid 26411362)
36. Neel JV 1962 Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 14:353-362
37. Hales CN, Barker DJ 1992 Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35:595-601
38. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM 1993 Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62-67 (Pubitemid 23018337)
39. Jansson T, Powell TL 2007 Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond) 113:1-13 (Pubitemid 47066020)
40. Dodic M, Moritz K, Wintour EM 2003 Prenatal exposure to glucocorticoids and adult disease. Arch Physiol Biochem 111:61-69 (Pubitemid 36398901)
41. Simmons RA 2007 Developmental origins of diabetes: the role of epigenetic mechanisms. Curr Opin Endocrinol Diabetes Obes 14:13-16 (Pubitemid 46375382)
42. Sai S, Esteves CL, Kelly V, Michailidou Z, Anderson K, Coll AP, Nakagawa Y, Ohzeki T, Seckl JR, Chapman KE 2008 Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta. Mol Endocrinol 22:2049-2060
43. Jamieson PM, Chapman KE, Seckl JR 1999 Tissue-and temporal-specific regulation of 11beta-hydroxysteroid dehydrogenase type 1 by glucocorticoids in vivo. J Steroid Biochem Mol Biol 68:245-250 (Pubitemid 29290661)
44. Ward AM, Syddall HE, Wood PJ, Chrousos GP, Phillips DI 2004 Fetal programming of the hypothalamic-pituitary-adrenal (HPA) axis: low birth weight and central HPA regulation. J Clin Endocrinol Metab 89:1227-1233 (Pubitemid 38368418)
45. Dahlgren J, Boguszewski M, Rosberg S, Albertsson-Wikland K 1998 Adrenal steroid hormones in short children born small for gestational age. Clin Endocrinol (Oxf) 49:353-361 (Pubitemid 28448946)
46. Putignano P, Pecori Giraldi F, Cavagnini F 2004 Tissue-specific dysregulation of 11beta-hydroxysteroid dehydrogenase type 1 and pathogenesis of the metabolic syndrome. J Endocrinol Invest 27:969-974 (Pubitemid 40124197)
47. Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR, Mullins JJ 2004 Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A 101:7088-7093 (Pubitemid 38596447)
48. Nair S, Lee YH, Lindsay RS, Walker BR, Tataranni PA, Bogardus C, Baier LJ, Permana PA 2004 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle. Diabetologia 47:1088-1095 (Pubitemid 38918169)
49. Bujalska IJ, Kumar S, Stewart PM 1997 Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349:1210-1213 (Pubitemid 27190044)
50. Andrew R, Phillips DI, Walker BR 1998 Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab 83:1806-1809 (Pubitemid 28501063)
51. Tiosano D, Eisentein I, Militianu D, Chrousos GP, Hochberg Z 2003 11 beta-Hydroxysteroid dehydrogenase activity in hypothalamic obesity. J Clin Endocrinol Metab 88:379-384 (Pubitemid 36115192)
52. Valsamakis G, Anwar A, Tomlinson JW, Shackleton CH, McTernan PG, Chetty R, Wood PJ, Banerjee AK, Holder G, Barnett AH, Stewart PM, Kumar S 2004 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. J Clin Endocrinol Metab 89:4755-4761 (Pubitemid 39244498)
53. Fraser R, Ingram MC, Anderson NH, Morrison C, Davies E, Connell JM 1999 Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension 33:1364-1368 (Pubitemid 29282655)
54. Meas T, Carreira E, Wang Y, Rauh M, Poitou C, Clement K, Dotsch J, Levy-Marchal C 2010 11beta-hydroxysteroid dehydrogenase type 1 of the subcutaneous adipose tissue is dysregulated but not associated with metabolic disorders in adults born small for gestational age. J Clin Endocrinol Metab 95:3949-3954
55. Dalla Pozza RD, Bechtold S, Putzker S, Bonfig W, Netz H, Schwarz HP 2006 Young adults born small for gestational age: is reduced baroreceptor sensitivity a risk factor for hypertension? Clin Cardiol 29:215-218
56. Buske-Kirschbaum A, Krieger S, Wilkes C, Rauh W, Weiss S, Hellhammer DH 2007 Hypothalamic-pituitary-adrenal axis function and the cellular immune response in former preterm children. J Clin Endocrinol Metab 92:3429-3435 (Pubitemid 47435315)